alternatives to glp-1 drugs for Employers GLP-1 drugs and muscle loss:
Description
2025;48(1 Suppl 1):S181206
The anti-inflammatory properties significantly aid in the therapy of metabolic syndrome
Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial
Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given Glucagon-Like Peptide-1 (GLP-1) receptor agonists
